AssetMark Inc Portfolio holdings
AssetMark runs an investment platform that financial advisors use to build portfolios for their clients and to handle the technology behind them. Financial advisor Ron Cordes and his partners started it in 1996 to solve a problem in their own practice, which was fitting investment strategies into a fee-based, fiduciary business. Cordes and his partners sold the company to Genworth Financial in 2006, and it operated under Genworth names until it took the AssetMark name in 2013. Advisors can place clients in model portfolios of mutual funds and ETFs, and AssetMark also runs its own mutual funds, the GuideMark and GuidePath families. Private equity firm GTCR owns AssetMark through a holding company, after earlier owners that included Aquiline Capital Partners and Genstar Capital.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ProShares Ultra S&P500
SSO
|
+$361M |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$279M |
| 3 |
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
|
+$226M |
| 4 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$132M |
| 5 |
Edison International
EIX
|
+$125M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$428M |
| 2 |
State Street SPDR Bloomberg High Yield Bond ETF
JNK
|
+$207M |
| 3 |
U.S. Core Equity 2 Portfolio ETF Class Shares
DFAC
|
+$119M |
| 4 |
iShares MSCI USA Momentum Factor ETF
MTUM
|
+$117M |
| 5 |
AT&T
T
|
+$102M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 64.1% |
| 2 | Technology | 12.54% |
| 3 | Financials | 4.9% |
| 4 | Communication Services | 4.81% |
| 5 | Healthcare | 3.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3551
Rhythm Pharmaceuticals
RYTM
$7.62B
| $286 | ﹤0.01% |
+3
| New | +$320 |
2026 Q3
0 quarters
|
|
3552
Bristow Group
VTOL
$1.15B
| $285 | ﹤0.01% |
7
+6
| +600% | +$265 |
2024 Q2
9 quarters
|
|
3553
Astrana Health
ASTH
$1.97B
| $285 | ﹤0.01% |
+8
| New | +$315 |
2026 Q3
0 quarters
|
|
3554
iShares MSCI Australia ETF
EWA
$1.27B
| $283 | ﹤0.01% |
10
| – | – |
2013 Q3
52 quarters
|
|
3555
Columbia Seligman Semiconductor and Technology ETF
SEMI
$42.5M
| $281 | ﹤0.01% |
7
| – | – |
2026 Q1
2 quarters
|
|
3556
World Kinect Corp
WKC
$1.94B
| $281 | ﹤0.01% |
8
-5
| -38% | -$181 |
2022 Q1
18 quarters
|
|
3557
NGL Energy Partners
NGL
$1.94B
| $280 | ﹤0.01% |
19
| – | – |
2026 Q1
2 quarters
|
|
3558
Daktronics
DAKT
$977M
| $278 | ﹤0.01% |
+16
| New | +$310 |
2026 Q3
0 quarters
|
|
3559
Globant
GLOB
$2.07B
| $278 | ﹤0.01% |
8
| – | – |
2024 Q2
9 quarters
|
|
3560
Infinity Natural Resources
INR
$235M
| $277 | ﹤0.01% |
+22
| New | +$301 |
2026 Q3
0 quarters
|
|
3561
Upstart Holdings
UPST
$2.28B
| $276 | ﹤0.01% |
12
-6
| -33% | -$172 |
2024 Q3
8 quarters
|
|
|
CBZ
3562
DELISTED
CBIZ
CBZ
| $273 | ﹤0.01% |
+5
| New | +$251 |
2026 Q3
0 quarters
|
|
3563
Penguin Solutions Inc
PENG
$2.48B
| $273 | ﹤0.01% |
+5
| New | +$284 |
2026 Q3
0 quarters
|
|
3564
Inspire 500 ETF
PTL
$867M
| $272 | ﹤0.01% |
+1
| New | +$281 |
2026 Q3
0 quarters
|
|
3565
Invesco S&P MidCap 400 GARP ETF
GRPM
$638M
| $271 | ﹤0.01% |
+2
| New | +$277 |
2026 Q3
0 quarters
|
|
3566
First Trust Small Cap Core AlphaDEX Fund
FYX
$1.41B
| $269 | ﹤0.01% |
+2
| New | +$283 |
2026 Q3
0 quarters
|
|
3567
Chagee Holdings Ltd
CHA
$2.44B
| $269 | ﹤0.01% |
+23
| New | +$259 |
2026 Q3
0 quarters
|
|
3568
VanEck Israel ETF
ISRA
$147M
| $267 | ﹤0.01% |
4
| – | – |
2025 Q3
4 quarters
|
|
3569
REX American Resources
REX
$1.31B
| $261 | ﹤0.01% |
6
+4
| +200% | +$175 |
2025 Q4
3 quarters
|
|
3570
Strategy Shares Nasdaq 7HANDL Index ETF
HNDL
$642M
| $259 | ﹤0.01% |
12
| – | – |
2024 Q2
9 quarters
|
|
3571
ProShares MSCI EAFE Dividend Growers ETF
EFAD
$67.1M
| $258 | ﹤0.01% |
6
| – | – |
2024 Q3
8 quarters
|
|
3572
ZoomInfo Technologies
GTM
$1.24B
| $258 | ﹤0.01% |
+68
| New | +$247 |
2026 Q3
0 quarters
|
|
3573
Eton Pharmaceutcials
ETON
$1.45B
| $257 | ﹤0.01% |
+5
| New | +$254 |
2026 Q3
0 quarters
|
|
3574
FirstService
FSV
$6.51B
| $256 | ﹤0.01% |
2
| – | – |
2024 Q2
9 quarters
|
|
3575
Invesco International Dividend Achievers ETF
PID
$895M
| $256 | ﹤0.01% |
12
| – | – |
2025 Q2
5 quarters
|
|
Similar funds
AssetMark Inc's Q3 2026 Portfolio in Review
As of Q3 2026, AssetMark Inc held 3,948 positions worth $59.5B, up 2.2% from $58.2B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
AssetMark Inc's Q3 2026 filing shows 390 new, 1,759 increased, 1,017 reduced and 175 closed positions. Its largest new stake was Invesco S&P 500 QVM Multi-factor ETF: 2,240,350 shares worth $101M. The largest sale was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $428M.
By sector, the portfolio is most concentrated in Miscellaneous at 64% of assets, down from 65% a quarter earlier, followed by Technology and Financials.
- AssetMark Inc's largest Q3 2026 buy was Invesco S&P 500 QVM Multi-factor ETF: 2,240,350 shares worth $101M.
- AssetMark Inc added most to ProShares Ultra S&P500 in Q3 2026, an estimated $361M increase.
- AssetMark Inc's biggest Q3 2026 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $428M.
- AssetMark Inc fully exited Taylor Morrison in Q3 2026, selling an estimated $11.9M.
- AssetMark Inc's ten largest holdings make up 29% of its $59.5B portfolio in Q3 2026.
- AssetMark Inc opened 390 new positions and closed 175 in Q3 2026.
- AssetMark Inc's portfolio value rose 2.2% quarter-over-quarter to $59.5B.
Based on AssetMark Inc's 13F filing for Q3 2026, filed 21 Oct 2026.